Last reviewed · How we verify
NCT03928626
Brief ROC Training Effects on Alcohol Drinking
NA trial testing Regulation of craving in Binge Drinking in 57 participants. Terminated before completion.
15 March 2020
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 57 |
| Start date | 10 April 2019 |
| Primary completion | 15 March 2020 |
| Estimated completion | 15 March 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Regulation of craving
- Control (NO REGULATION)
Conditions studied
- Binge Drinking — all drugs for Binge Drinking →
- Heavy Drinking — all drugs for Heavy Drinking →
- Young Adult — all drugs for Young Adult →
- Heavy Drinker — all drugs for Heavy Drinker →
Sponsor
Yale University
Who can join
Adults 18 to 25, any sex, with Binge Drinking or Heavy Drinking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the proposed study is to examine whether a single session of training in regulation of craving (ROC-T) affects alcohol drinking. The study will consist of (1) a basic screening (phone and/or online) and an in-person visit, to determine eligibility and conduct pre-intervention baseline assessments; (2) a training (ROC-T) visit, (3) a post-intervention assessment visit, and (4) 1-2 phone/online follow-up assessments. The study will take up to 10 hours of the participants' time.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03928626
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Binge Drinking
Currently open trials in the same condition.
- NCT06595862 — Open Pilot Trial Evaluating an Avatar-Guided Intervention for Emerging Adults With Alcohol Use Problems and Suicide Risk · NA · active not recruiting
- NCT06687525 — Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study · recruiting
- NCT06447350 — Alcohol Consumption: Norms, Identities, & Motivations · NA · recruiting
- NCT06318975 — Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use · NA · recruiting
- NCT05946083 — The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning · Phase 2 · recruiting
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03928626 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03928626.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing